Statins Do Not Reduce The Risk Of Colon Cancer

Statins Do Not Reduce The Risk Of Colon Cancer.
Statins don't condescend the chance of colorectal cancer, and may even heighten the chances of developing precancerous polyps, green research suggests for more info. Statins are widely prescribed cholesterol-lowering drugs sold in a genre of generic forms and identify names, including Lipitor, Crestor and Zocor.

Yet, researchers stressed that the results are "not conclusive," and that bourgeoisie taking statins to tone down cholesterol and reduce their risk of heart attack should continue taking the drugs. "We found patients in this work taking statins for more than three years tended to reveal more premalignant colon lesions," said consider author Dr Monica Bertagnolli, chief of the division of surgical oncology at Brigham and Women's Hospital and a professor of surgery at Harvard Medical School. "This is an inviting declaration that needs to be followed up, but it should not bring up alarm. No one should stop taking their statins."

The survey is to be presented Monday at the American Association for Cancer Research annual convergence in Washington, DC, and it is also published online in the periodical Cancer Prevention Research. The data used in the enquiry was from an earlier clinical trial to determine if the cox-2 anaesthetic celecoxib (Celebrex) could be used to prevent colon cancer.

That effort included 2035 people who were at high risk of colon cancer and had already been diagnosed with precancerous polyps, or adenomas. That study, published in 2006, found the celecoxib reduced the incident of adenomas, but it also more than doubled the endanger of nub attack and other serious cardiac events.